Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) [Phase 3]
This document reports the completion and results of a Phase 3 clinical trial evaluating an optimized treatment algorithm for patients with e…
-
FDA approval · 2015-11-23FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) filed by Cordavis Limited, indicating regulatory action on a Humira supp…
-
CLINICAL_TRIALS trial_result · 2015-11-23Clinical Trial Update: An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis
This is an observational study evaluating tocilizumab as monotherapy for rheumatoid arthritis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis [Phase 3]
Phase 3 efficacy confirmation study of CDP870 in early rheumatoid arthritis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017) [Phase 2]
A Phase 2 efficacy and safety study of MK0359 in rheumatoid arthritis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: 24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate [Phase 2]
A 24-week Phase 2 trial of VX-509 (an oral JAK3 inhibitor) in rheumatoid arthritis patients taking methotrexate has completed, including an …
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: A Phase 2/3 Open-label Extension Study to Evaluate Long-Term Safety and Efficacy With VX-509 in Subjects With Rheumatoid Arthritis [Phase 2, Phase 3]
This Phase 2/3 open-label extension study evaluated the long-term safety and efficacy of VX-509 in rheumatoid arthritis and has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Tear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients
This clinical trial update describes analyses of tear proteins, conjunctival cells, and eye imaging in patients with dry eye disease. It inc…
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects [Phase 1]
Phase 1 trial assessing safety and tolerability of MORAb-022 in healthy subjects and rheumatoid arthritis patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870 [Phase 3]
This document reports on the completion of a long-term Phase 3 study evaluating self-injected certolizumab pegol (CDP870) in adults with act…
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)
This update indicates that the clinical trial evaluating Certolizumab Pegol for active Rheumatoid arthritis and Crohn's disease has been ter…
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Safety and Efficacy of the Combination of Diacerein 100 mg Daily and MTX Versus MTX Alone in the Treatment of Early Rheumatoid Arthritis (RA) [Phase 2]
A Phase 2 study evaluating whether adding diacerein (100 mg daily) to methotrexate improves safety and efficacy in early rheumatoid arthriti…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA) [Phase 3]
Phase 3 study evaluating the safety and efficacy of golimumab (Simponi) in active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 3]
A Phase 3 study of tocilizumab (RoActemra/Actemra) in patients with moderate-to-severe rheumatoid arthritis has been completed, with results…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Consequences of Anti-interleukin 6 Immunotherapy Treatment for Rheumatoid Arthritis on Periodontium [Phase 4]
Phase 4 trial evaluating the effects of anti-IL-6 immunotherapy for rheumatoid arthritis on the periodontium; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Study to Assess Safety, Tolerability, and Pharmacokinetics of Oral Doses for AC430 in Healthy Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of oral AC430 in healthy subjects; completed.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDS [Phase 4]
This entry reports the completion and posting of results for a Phase 4 study evaluating tocilizumab (RoActemra/Actemra) in adults with activ…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: Mexican Initiative of Patients With Osteoarthritis and Rheumatoid Arthritis (IMPACTAR)
A completed clinical trial update for the Mexican Initiative of Patients with Osteoarthritis and Rheumatoid Arthritis (IMPACTAR).
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008) [Phase 2]
A Phase 2 efficacy, tolerability and safety study in rheumatoid arthritis has completed, sponsored by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS research · 2015-10-16Clinical Trial Update: Associations Between Periodontitis and Autoimmune Antibodies in Rheumatoid Arthritis Disease
A clinical trial update exploring the association between periodontitis and autoimmune antibodies in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: 25-hydroxyvitamin D and Fatigue: The VITALITY Study
The VITALITY study evaluating 25-hydroxyvitamin D and fatigue has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository
This update summarizes treatment efficacy and toxicity findings from a rheumatoid arthritis database and repository. The study is completed …
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis [Phase 2]
Phase 2 proof-of-concept trial evaluating BMS-817399 for moderate to severe rheumatoid arthritis. The study has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: PoC in Rheumatoid Arthritis With Methotrexate [Phase 2]
Phase 2 proof-of-concept trial in rheumatoid arthritis evaluating a Bristol-Myers Squibb investigational agent in combination with methotrex…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis
An observational study evaluating tocilizumab (Actemra) in adults with moderate to severe rheumatoid arthritis has completed, with results p…